The immunosuppressive tumor microenvironment is established by recruiting immunosuppressive cells and tumor cell-derived immunosuppressive cytokines, such as VEGF, TGF-β, galectin, or indoleamine 2-3-dioxygenase (32). The gene discussed is TGFB1; the disease is neoplasm.